IBDEI15A ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19477,1,3,0)
 ;;=3^Erythema Intertrigo
 ;;^UTILITY(U,$J,358.3,19477,1,4,0)
 ;;=4^L30.4
 ;;^UTILITY(U,$J,358.3,19477,2)
 ;;=^5009157
 ;;^UTILITY(U,$J,358.3,19478,0)
 ;;=L30.8^^84^918^135
 ;;^UTILITY(U,$J,358.3,19478,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19478,1,3,0)
 ;;=3^Dermatitis NEC
 ;;^UTILITY(U,$J,358.3,19478,1,4,0)
 ;;=4^L30.8
 ;;^UTILITY(U,$J,358.3,19478,2)
 ;;=^5009158
 ;;^UTILITY(U,$J,358.3,19479,0)
 ;;=L30.9^^84^918^136
 ;;^UTILITY(U,$J,358.3,19479,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19479,1,3,0)
 ;;=3^Dermatitis,Unspec
 ;;^UTILITY(U,$J,358.3,19479,1,4,0)
 ;;=4^L30.9
 ;;^UTILITY(U,$J,358.3,19479,2)
 ;;=^5009159
 ;;^UTILITY(U,$J,358.3,19480,0)
 ;;=L40.0^^84^918^253
 ;;^UTILITY(U,$J,358.3,19480,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19480,1,3,0)
 ;;=3^Psoriasis Vulgaris
 ;;^UTILITY(U,$J,358.3,19480,1,4,0)
 ;;=4^L40.0
 ;;^UTILITY(U,$J,358.3,19480,2)
 ;;=^5009160
 ;;^UTILITY(U,$J,358.3,19481,0)
 ;;=L40.1^^84^918^256
 ;;^UTILITY(U,$J,358.3,19481,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19481,1,3,0)
 ;;=3^Pustulosis Psoriasis,Generalized
 ;;^UTILITY(U,$J,358.3,19481,1,4,0)
 ;;=4^L40.1
 ;;^UTILITY(U,$J,358.3,19481,2)
 ;;=^5009161
 ;;^UTILITY(U,$J,358.3,19482,0)
 ;;=L40.2^^84^918^11
 ;;^UTILITY(U,$J,358.3,19482,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19482,1,3,0)
 ;;=3^Acrodermatitis Continua
 ;;^UTILITY(U,$J,358.3,19482,1,4,0)
 ;;=4^L40.2
 ;;^UTILITY(U,$J,358.3,19482,2)
 ;;=^5009162
 ;;^UTILITY(U,$J,358.3,19483,0)
 ;;=L40.3^^84^918^255
 ;;^UTILITY(U,$J,358.3,19483,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19483,1,3,0)
 ;;=3^Pustulosis Palmaris et Plantaris
 ;;^UTILITY(U,$J,358.3,19483,1,4,0)
 ;;=4^L40.3
 ;;^UTILITY(U,$J,358.3,19483,2)
 ;;=^5009163
 ;;^UTILITY(U,$J,358.3,19484,0)
 ;;=L40.4^^84^918^157
 ;;^UTILITY(U,$J,358.3,19484,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19484,1,3,0)
 ;;=3^Guttate Psoriasis
 ;;^UTILITY(U,$J,358.3,19484,1,4,0)
 ;;=4^L40.4
 ;;^UTILITY(U,$J,358.3,19484,2)
 ;;=^5009164
 ;;^UTILITY(U,$J,358.3,19485,0)
 ;;=L40.8^^84^918^252
 ;;^UTILITY(U,$J,358.3,19485,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19485,1,3,0)
 ;;=3^Psoriasis NEC
 ;;^UTILITY(U,$J,358.3,19485,1,4,0)
 ;;=4^L40.8
 ;;^UTILITY(U,$J,358.3,19485,2)
 ;;=^271917
 ;;^UTILITY(U,$J,358.3,19486,0)
 ;;=L40.9^^84^918^254
 ;;^UTILITY(U,$J,358.3,19486,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19486,1,3,0)
 ;;=3^Psoriasis,Unspec
 ;;^UTILITY(U,$J,358.3,19486,1,4,0)
 ;;=4^L40.9
 ;;^UTILITY(U,$J,358.3,19486,2)
 ;;=^5009171
 ;;^UTILITY(U,$J,358.3,19487,0)
 ;;=L50.9^^84^918^286
 ;;^UTILITY(U,$J,358.3,19487,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19487,1,3,0)
 ;;=3^Urticaria,Unspec
 ;;^UTILITY(U,$J,358.3,19487,1,4,0)
 ;;=4^L50.9
 ;;^UTILITY(U,$J,358.3,19487,2)
 ;;=^5009204
 ;;^UTILITY(U,$J,358.3,19488,0)
 ;;=L53.8^^84^918^147
 ;;^UTILITY(U,$J,358.3,19488,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19488,1,3,0)
 ;;=3^Erythematous Conditions NEC
 ;;^UTILITY(U,$J,358.3,19488,1,4,0)
 ;;=4^L53.8
 ;;^UTILITY(U,$J,358.3,19488,2)
 ;;=^88044
 ;;^UTILITY(U,$J,358.3,19489,0)
 ;;=L53.9^^84^918^146
 ;;^UTILITY(U,$J,358.3,19489,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19489,1,3,0)
 ;;=3^Erythematous Condition,Unspec
 ;;^UTILITY(U,$J,358.3,19489,1,4,0)
 ;;=4^L53.9
 ;;^UTILITY(U,$J,358.3,19489,2)
 ;;=^5009210
 ;;^UTILITY(U,$J,358.3,19490,0)
 ;;=L54.^^84^918^145
 ;;^UTILITY(U,$J,358.3,19490,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19490,1,3,0)
 ;;=3^Erythema in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,19490,1,4,0)
 ;;=4^L54.
 ;;^UTILITY(U,$J,358.3,19490,2)
 ;;=^5009211
